Cargando…

Efficacy and Safety of DaxibotulinumtoxinA for Injection in the Treatment of Glabellar Lines by Age and Race: Subgroup Analysis of the SAKURA Clinical Trials

BACKGROUND: DaxibotulinumtoxinA for Injection (DAXI) is a novel botulinum toxin type A formulation approved for the treatment of glabellar lines. The efficacy, safety, and extended duration of response of DAXI 40 U for glabellar lines were demonstrated in 2 Phase 3, randomized, double-blind studies...

Descripción completa

Detalles Bibliográficos
Autores principales:	Solish, Nowell, Burgess, Cheryl M, Weinkle, Susan H, Ablon, Glynis, Brown, Jessica, Kooken, Kristie, Rubio, Roman G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9896135/ https://www.ncbi.nlm.nih.gov/pubmed/36087303 http://dx.doi.org/10.1093/asj/sjac246

Ejemplares similares

A Large, Open-Label, Phase 3 Safety Study of DaxibotulinumtoxinA for Injection in Glabellar Lines: A Focus on Safety From the SAKURA 3 Study
por: Green, Jeremy B., et al.
Publicado: (2021)

Impact of Glabellar Injection Technique With DaxibotulinumtoxinA for Injection on Brow Position
por: Bertucci, Vince, et al.
Publicado: (2022)

Immunogenicity of DaxibotulinumtoxinA for Injection in Glabellar Lines
por: Humphrey, Shannon, et al.
Publicado: (2023)

Clinical Immunogenicity of DaxibotulinumtoxinA for Injection in Glabellar Lines: Pooled Data from the SAKURA Phase 3 Trials
por: Gallagher, Conor J., et al.
Publicado: (2023)

Impact of DaxibotulinumtoxinA for Injection on Brow Position and Frontalis Muscle Activity Following Treatment of Glabellar Lines
por: Solish, Nowell, et al.
Publicado: (2022)

DaxibotulinumtoxinA for Injection for the Treatment of Glabellar Lines: Results from Each of Two Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Studies (SAKURA 1 and SAKURA 2)
por: Carruthers, Jean D., et al.
Publicado: (2020)

Bridging the Gap: Sustained Treatment Effect of Glabellar Lines With Twice-A-Year Treatment With DaxibotulinumtoxinA
por: Dover, Jeffrey S., et al.
Publicado: (2023)

DaxibotulinumtoxinA for Injection for the Treatment of Glabellar Lines: Efficacy Results From SAKURA 3, a Large, Open-Label, Phase 3 Safety Study
por: Fabi, Sabrina G., et al.
Publicado: (2021)

Overview of DaxibotulinumtoxinA for Injection: A Novel Formulation of Botulinum Toxin Type A
por: Solish, Nowell, et al.
Publicado: (2021)

Progressive Improvement in Static Glabellar Lines After Repeated Treatment With DaxibotulinumtoxinA for Injection
por: Glogau, Richard, et al.
Publicado: (2021)

Prior Botulinum Toxin Treatment Does Not Impact Efficacy or Safety in Clinical Trials: Analysis of DaxibotulinumtoxinA for Injection in the SAKURA Program
por: Cohen, Joel L., et al.
Publicado: (2021)

Injectable DaxibotulinumtoxinA in Cervical Dystonia: A Phase 2 Dose‐Escalation Multicenter Study
por: Jankovic, Joseph, et al.
Publicado: (2018)

DAXI (DaxibotulinumtoxinA) – An Innovative Approach for Frown Lines
por: Mussarat, Abdullah, et al.
Publicado: (2023)

Treatment of Upper Facial Lines With DaxibotulinumtoxinA for Injection: Results From an Open-Label Phase 2 Study
por: Dover, Jeffrey S., et al.
Publicado: (2023)

Optimizing Outcomes When Treating Glabellar Lines
por: Solish, Nowell, et al.
Publicado: (2023)

Subject satisfaction and psychological well‐being with escalating abobotulinumtoxinA injection dose for the treatment of moderate to severe glabellar lines
por: Dayan, Steven, et al.
Publicado: (2022)

Sakura : tercinas del oriente remoto
por: Monterde, Francisco, 1894-1985
Publicado: (1963)

Long-term Efficacy of Satralizumab in AQP4-IgG–Seropositive Neuromyelitis Optica Spectrum Disorder From SAkuraSky and SAkuraStar
por: Kleiter, Ingo, et al.
Publicado: (2022)

The Crest Injection Technique for Glabellar Line Correction and the Paracentral Artery
por: Tansatit, Tanvaa, et al.
Publicado: (2021)

Anatomical Proposal for Botulinum Neurotoxin Injection for Glabellar Frown Lines
por: Yi, Kyu-Ho, et al.
Publicado: (2022)

Acute diplopia after glabellar hyaluronic acid filler injection
por: Chung, Caroline W., et al.
Publicado: (2023)

A 3-Month, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Ability of an Extra-Strength Marine Protein Supplement to Promote Hair Growth and Decrease Shedding in Women with Self-Perceived Thinning Hair
por: Ablon, Glynis
Publicado: (2015)

Understanding How to Prevent and Treat Adverse Events of Fillers and Neuromodulators
por: Ablon, Glynis
Publicado: (2016)

Angiomyolipoma of the Glabellar Region
por: Kim, Hyo Joong, et al.
Publicado: (2017)

Sakura-based activated carbon preparation and its performance in supercapacitor applications
por: Ma, Fei, et al.
Publicado: (2019)

Psoriatic Lesions Following Botulinum Toxin: A Injections to the Glabellar Region
por: Ceran, Candemir, et al.
Publicado: (2015)

Ophthalmic artery occlusion after glabellar hyaluronic acid filler injection
por: Davidova, Petra, et al.
Publicado: (2022)

Anatomical Injection Guidelines for Glabellar Frown Lines Based on Ultrasonographic Evaluation
por: Kim, Soo-Bin, et al.
Publicado: (2021)

PrabotulinumtoxinA vs OnabotulinumtoxinA for the Treatment of Adult Males With Moderate to Severe Glabellar Lines: Post-hoc Analyses of the Phase III Clinical Study Data
por: Solish, Nowell, et al.
Publicado: (2022)

The complete mitochondrial genome sequence of the sakura shrimp, Sergia lucens (Crustacea, Decapoda, Sergestidae)
por: Kawato, Satoshi, et al.
Publicado: (2018)

A Retrospective Study of Chinese-Specific Glabellar Contraction Patterns
por: Hsieh, Daniel Meng-Yen, et al.
Publicado: (2019)

Glabellar Presentation, Its Incidence and Termination
por: Mudaliar, A. L.
Publicado: (1934)

Glabellar flap technique in oculoplastic surgery
por: Balchev, Georgi, et al.
Publicado: (2022)

Glabellar and auricular leukemia cutis in CLL
por: Steinman, Bradley, et al.
Publicado: (2022)

Key Parameters for the Use of AbobotulinumtoxinA in Aesthetics: Onset and Duration
por: Nestor, Mark, et al.
Publicado: (2017)

Commentary: A technical revisit to the glabellar flap
por: Singh, Manpreet, et al.
Publicado: (2022)

Current use of direct oral anticoagulants for atrial fibrillation in Japan: Findings from the SAKURA AF Registry
por: Okumura, Yasuo, et al.
Publicado: (2017)

Botulinum toxin type-A in the treatment of glabellar lines
por: Winter, Leslie, et al.
Publicado: (2009)

Botulinum toxin type A for the management of glabellar rhytids
por: Tremaine, Anne Marie, et al.
Publicado: (2010)

Diagnostic accuracy of glabellar tap sign for Parkinson’s disease
por: Nuuttila, Simo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bq6roevmgclvau97fta9md57ap